About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials | 4,039 Studies Recruiting

Clinical TrialsOvarian Cancer

Ovarian Cancer Clinical Trials

Browse 4,039 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3061-3080 of 4,039 trials

CompletedTLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00022347·New York, New York CompletedCabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity CancerThis randomized phase II trial studies how well giving cabozantinib-s-malate or paclitaxel works in treating patients with persistent or recurrent epithelial ovarian, fallopian…NCT01716715·Mobile, Alabama and 172 others

Related Searches

ovary cancertrials

Data from ClinicalTrials.govTerms

RecruitingDeveloping New Educational Materials About Genetic Testing for a Diverse Group of Cancer PatientsGenetic testing is a type of test that detects changes to the genes-the DNA instructions that are passed on from the mother and father.NCT04751435·Brooklyn, New York and 3 others

CompletedLetrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 MutationRATIONALE: Letrozole may prevent breast cancer in postmenopausal women with a BRCA1 or BRCA2 mutation.NCT00673335·Avignon and 22 others

CompletedA Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the ElectrocardiogramThe purpose of this study is to assess the potential effects of trabectedin on the QT/QTc interval duration measured by electrocardiograms (ECGs) in participants with advanced…NCT00786838·Miami, Florida and 16 others

Active not recruitingAscending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer AgentsThis is a modular, phase I/ phase 1 b, open-label, multicentre study of ceralasertib administered orally in combination with cytotoxic chemotherapy regimens and/or novel…NCT02264678·Duarte, California and 27 others

Completedp53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246The purpose of this study is to make a preliminary assessment of the efficacy of a combined APR-246 and carboplatin/PLD chemotherapy regimen, compared with carboplatin/PLD…NCT02098343·Los Angeles, California and 54 others

TerminatedA Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)This study will determine the best doses of docetaxel and lonafarnib when the two anti-cancer agents are used in combination.NCT00539968

CompletedA Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsThis is a Phase I, open-label, multi-center, competitive enrollment and dose-escalation study of ALT-836 in combination with standard of care gemcitabine in participants who have…NCT01325558·Atlanta, Georgia and 3 others

RecruitingA Study of DC05F01 in Chinese Patients With Recurrent/Refractory Ovarian Cancer and Other Advanced Solid TumorsThis study is a multicenter, open-label, cohort expansion Phase Ib/IIa trial designed to evaluate the efficacy, safety, and pharmacokinetic (PK) profile of DC05F01 in patients…NCT06873555·Bengbu, Anhui and 1 other

UnknownThe Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort StudyOvarian cancer is associated with the highest mortality of all gynecologic cancers.NCT05265117·Guangzhou, Guangdong

TerminatedA Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced CancerThe purpose of this study is to determine the tolerability profile of OPB-111001 and to determine the most suitable dose of OPB-111001 in patients with advanced cancerNCT02042885·London, Sutton, Surrey and 1 other

UnknownA Cohort Establishment Study of Total Management of Ovarian CancerA cohort establishment study of total management of ovarian cancer (including fallopian tube cancer and primary peritoneal cancer).NCT06018935·Chengdu

UnknownMapping Sentinel Lymph Node in Initial Stages of Ovarian CancerEpithelial ovarian cancer (EOC) diagnosed in the initial stage (stage I-II) require complete staging surgery to histologically assess the possible existence of peritoneal or lymph…NCT05184140·Barcelona

CompletedPhase 1 Dose Escalation Study for VIP236 in Patients With Advanced CancerDetermine the safety, tolerability, and maximum tolerated dose (MTD) of IV administered VIP236 as monotherapy in patients with advanced solid tumor cancerNCT05712889·Scottsdale, Arizona and 5 others

CompletedStudy of Circulating Tumoral DNA in Ovarian CancerCirculating tumor DNA detection and quantification in patients with ovarian cancer.NCT01350908·Paris

RecruitingA Clinical Study of SYS6041 Combination Therapy for Recurrent Ovarian CancerThis is an open-label, multicenter Phase II clinical study conducted in subjects with recurrent ovarian cancer.NCT07714668·Shanghai, Shanghai Municipality

CompletedPharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment PatientsNiraparib (Zejula®)is extensively metabolized and eliminated primarily by hepatic and renal pathways.NCT03359850·Los Angeles, California and 4 others

CompletedGene Therapy in Treating Patients With CancerRATIONALE: Inserting a gene that has been created in the laboratory into a person's white blood cells may make the body build an immune response to kill cancer cells.NCT00004178·Boston, Massachusetts

UnknownApatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian CancerThe study was designed to evaluate the efficacy and safety of apatinib with albumin-bound paclitaxel in patients with platinum-resistant recurrent ovarian cancer.NCT03942068

PreviousPage 154 of 202Next